首页> 外文会议>American Institute of Chemical Engineers annual meeting >(125c) Novel, Synthetic, Tetracycline-Inducible Transcription Regulators for E. Coli
【24h】

(125c) Novel, Synthetic, Tetracycline-Inducible Transcription Regulators for E. Coli

机译:(125C)大肠杆菌的新型,合成,四环素诱导的转录调节调节剂

获取原文

摘要

We are designing, constructing and characterizing novel synthetic gene regulators. These regulators range from individual inducible fusion protein and promoter pairs to complex nonlinear regulatory networks. All of the regulators are designed to be compatible in E. coli and to control gene expression by direct transcription activation. Our investigations have complementary experimental and computer modeling components which allow us to build and characterize these complex and robust synthetic systems while reducing the required expense and effort to construct future networks. Our initial focus has been on designing, constructing and characterizing two-part synthetic regulatory systems. They are composed of an inducible fusion regulatory protein and a complementary fusion promoter. The fusion proteins are novel combinations of the inducible DNA binding tetracycline represser (TetR) or its derivative reverse-TetR (rTetR), and the transcription activation domain LuxRAN(2-162) (LuxRAN). The fusion promoter contains the complementary operator sequences, tetO and luxbox, for TetR/rTetR and LuxRAN respectively. We are experimentally characterizing the systems' gene expression regulation using real-time PCR, immunoblotting, culture fluorescence and flow cytometry while making small adjustments for optimization. In parallel, we are building and testing stochastic models with the aim of accurately capturing the systems' behavior, independent of context. Real-time PCR results indicate that the rTetR-LuxRAN facilitates significant transcription upregulation upon induction by anhydrous tetracycline (aTc). We also observe a parallel increase in protein synthesis, monitoring mean culture fluorescence and individual cell analysis by flow cytometry. After induction with aTc, the transcription activator upregulates target gene expression, initiating the emergence of a cell population with GFP expression 2 orders of magnitude above the uninduced population.
机译:我们正在设计,构建和表征新的合成基因调节剂。这些调节器范围从个体诱导融合蛋白和启动子对复合非线性调节网络。所有调节剂都设计成在大肠杆菌中相容并通过直接转录激活来控制基因表达。我们的调查具有互补的实验和计算机建模组件,允许我们建立和表征这些复杂和强大的合成系统,同时降低了构建未来网络所需的费用和努力。我们的初始重点一直在设计,构建和表征两部分合成监管系统。它们由诱导型融合调节蛋白和互补融合促进剂组成。融合蛋白是诱导型DNA结合四环素抑制剂(四)或其衍生物反向 - 四(retIT rotOr)的新组合,以及转录活化域Luxran(2-162)(Luxran)。融合促进剂分别含有互补算子序列,Teto和Luxbox,分别用于圆环/ relran和Luxran。我们使用实时PCR,免疫印迹,培养荧光和流式细胞术进行了实验表征系统的基因表达调节,同时进行了微小的优化调整。并行,我们正在建设和测试随机模型,目的是准确地捕获系统的行为,与上下文无关。实时PCR结果表明,RTINGRUNRAN通过无水四环素(ATC)诱导时促进了显着的转录上调。我们还观察到蛋白质合成的平行增加,通过流式细胞术监测平均培养荧光和单个细胞分析。在用ATC感应后,转录激活剂上调靶基因表达,从而引发细胞群的出现,GFP表达2次数高于未胁迫人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号